VYNDAQEL 20 MG CAP MOLE CT BL AL PLAS TRANS X 120

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1211004620023
  • GGREM 522720050085407
  • Código de barras 7891268187113

O que a fonte publica

Detentor do registro
PFIZER BRASIL LTDA
Princípios ativos
TAFAMIDIS MEGLUMINA
Embalagem
20 MG CAP MOLE CT BL AL PLAS TRANS X 120
Regime de dispensação
Tarja Vermelha
Tipo de produto
Novo
Classe terapêutica
N7X - TODOS OS OUTROS PRODUTOS PARA O SISTEMA NERVOSO CENTRAL
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:522720050085407
{
  "name": "VYNDAQEL 20 MG CAP MOLE CT BL AL PLAS TRANS X 120",
  "holder": "PFIZER BRASIL LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7891268187113"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "522720050085407",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "61.072.393/0001-33",
  "priceRegime": "Regulado",
  "productName": "VYNDAQEL",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "20 MG CAP MOLE CT BL AL PLAS TRANS X 120",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "107365.35",
    "icms-12": "122006.12",
    "icms-17": "129355.81",
    "icms-18": "130933.33",
    "icms-19": "132549.83",
    "icms-20": "134206.69",
    "icms-21": "135905.53",
    "icms-22": "137647.85",
    "icms-23": "139435.49",
    "icms-17.5": "130139.80",
    "icms-19.5": "133373.10",
    "icms-20.5": "135050.79",
    "icms-22.5": "138535.98",
    "icms-12-alc": "108934.07",
    "icms-17-alc": "115496.24",
    "icms-18-alc": "116904.76",
    "icms-19-alc": "118347.97",
    "icms-20-alc": "119827.35",
    "icms-21-alc": "121344.21",
    "icms-22-alc": "122899.83",
    "icms-23-alc": "124495.92",
    "withoutTaxes": "95861.90",
    "icms-17.5-alc": "116196.26",
    "icms-19.5-alc": "119083.10",
    "icms-20.5-alc": "120580.95",
    "icms-22.5-alc": "123692.72"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "TAFAMIDIS MEGLUMINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "144026.79",
    "icms-12": "163666.87",
    "icms-17": "173526.21",
    "icms-18": "175642.40",
    "icms-19": "177810.88",
    "icms-20": "180033.50",
    "icms-21": "182312.43",
    "icms-22": "184649.69",
    "icms-23": "187047.75",
    "icms-17.5": "174577.91",
    "icms-19.5": "178915.27",
    "icms-20.5": "181165.83",
    "icms-22.5": "185841.08",
    "icms-12-alc": "150594.96",
    "icms-17-alc": "159666.78",
    "icms-18-alc": "161613.97",
    "icms-19-alc": "163609.13",
    "icms-20-alc": "165654.28",
    "icms-21-alc": "167751.25",
    "icms-22-alc": "169901.81",
    "icms-23-alc": "172108.31",
    "withoutTaxes": "132523.46",
    "icms-17.5-alc": "160634.51",
    "icms-19.5-alc": "164625.40",
    "icms-20.5-alc": "166696.09",
    "icms-22.5-alc": "170997.93"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "TAFAMIDIS MEGLUMINA"
  ],
  "therapeuticClass": "N7X - TODOS OS OUTROS PRODUTOS PARA O SISTEMA NERVOSO CENTRAL",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1211004620023",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "N7X",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:522720050085407"